We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where Roivant ...

Shares of Roivant Sciences stock opened at $11.92 on Friday. Roivant Sciences Ltd. has a 12-month low of $8.24 and a 12-month high of $13.24. The stock has a market cap of $8.81 billion ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bluebird Bio (BLUE – Research Report), ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Check the time stamp on this data. Updated AI-Generated Signals for Roivant Sciences Ltd. (ROIV) available here: ROIV.

In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on Argenx Se (ARGX – Research Report), with a ...

Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

Some Republican politicians, such as Vivek Ramaswamy — former presidential candidate and the owner of pharmaceutical company ...

Roivant Sciences Ltd. (ROIV) reported Q2 EPS of ($0.42), $0.04 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $12.53 million versus the consensus ...

On Tuesday, Goldman Sachs revised its stock price target for Roivant Sciences (NASDAQ:ROIV), increasing it to $18 from the previous $16, while maintaining a Buy rating. The... On Tuesday, Roivant ...